News

Amanda Smith has kicked insulin to the curb in what experts are calling a milestone in the fight against Type 1 diabetes.
Cells once thought passive are now seen as sculptors. Their choreography may explain how tissues form and fail. A new study ...
The American Society for Transplantation and Cellular Therapy is proud to announce the release of a refreshed Practice ...
Donor stem cells for the allogeneic transplantation came from Germany, India and Chile ...
A 20-year-old is on his "last chance" at finding "lifesaving" treatment after he was told devastating news just days after ...
‘Skin problems often start to go away once treatment for lymphoma starts.’ Itchy skin is not always a sign of anything ...
Some of the most harmful genetic changes in cancer are also the hardest to see. These structural alterations, deep within a ...
Patients with blood cancers like polycythemia vera, a kind of myeloproliferative neoplasm, may benefit in learning more about ...
Dr. Omar H. Llaguna, specialist in surgical oncology, programs a HistoSonics medical device for targeting a medium that ...
Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes.
Trials enrolling patients with relapsed leukemia, lymphoma and brain cancers, respectively, report early data showing ...
In a first for the bloc, Europe’s Committee for Medicinal Products for Human Use (CHMP) has recommended marketing ...